Butterfly Network (NYSE: BFLY) announced today that Canada has approved its second-generation iQ+.
Butterfly Network touts the iQ+ features what the company describes as the world’s only Ultrasound-on-Chip technology, boasting hardware and software advances to improve usability and care delivery.
“We are excited that the Butterfly iQ+ will now be available for purchase by Canadian medical professionals,” said Butterfly Network CEO Dr. Todd Fruchterman. “Thousands of new practitioners and millions of patients will now have access to a transformative advanced assessment tool that can deliver valuable insights that enable more informed clinical decisions at the point of care.”
The IQ+ is now available in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.